Status:
COMPLETED
Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
Lead Sponsor:
B. Braun Melsungen AG
Conditions:
Intensive Care Patients
Eligibility:
All Genders
Brief Summary
Glucose metabolism is impaired in many critically ill patients and is often aggravated by parenteral feeding, infections and/or pre-existent diabetes.Therefore insulin infusion protocols, which are ba...
Eligibility Criteria
Inclusion
- Inclusion:
- Intensive care patients who require blood glucose control by intravenous application of insulin
- Exclusion:
- All contraindication of intravenous insulin therapy
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT01523665
Start Date
October 1 2011
End Date
July 1 2013
Last Update
November 27 2013
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational Site
Hradec Králové, Czechia
2
Investigational Site
Pilsen, Czechia
3
Investigational sites
Prague, Czechia
4
Rigshospitalet Copenhagen
Copenhagen, Denmark